Clinical Research: Phase 1 - Phase 4

Informed Strategy Key to Drug Development Innovation, Premier Research Says in Naming Regulatory Chief

DURHAM, N.C., June 27, 2016 — Small biotechnology companies taking new biopharmaceutical products from benchtop to bedside need an informed regulatory strategy and a close working knowledge of the Food and Drug Administration and other regulatory agencies. So when it sought a new head of regulatory affairs, clinical development service provider Premier Research found its ideal...

Premier Research Bolsters Rare Disease and Oncology Drug Development Expertise with New Hires

DURHAM, N.C., June 13, 2016 — Premier Research is expanding its international organization of experts in rare disease amid continued growth in the field — especially in rare oncology, which has surpassed one-third of the company’s rare disease work. “Development of novel compounds for treatment of unmet medical needs historically has been overlooked by big pharma,...

Other

Premier Research Names Michael King Jolly Senior Vice President

PHILADELPHIA, February 02, 2016 — Premier Research announces the appointment of Michael King Jolly, Pharm.D., as Senior Vice President. In this newly created position, Dr. Jolly oversees drug development partnerships and develops innovative offerings for the company, a leader in clinical development for the biotech and specialty pharma sectors. With more than 30 years of...